Mineralys Therapeutics Total Assets

Mineralys Therapeutics (MLYS) currently reports a total assets of $650M as of March 2026. That compares with $350M in the prior-year period — up 83.9% year over year. Use the charts on this page to explore Mineralys Therapeutics's total assets history and peer comparisons.

Mineralys Therapeutics's total assets increased from $350M to $650M — a 83.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mineralys Therapeutics reported $650M in total assets as of March 2026. That compares with $350M in the prior-year period — up 83.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $650M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mineralys Therapeutics, and consider following MLYS for alerts when major investors trade the stock.